Skip to main content

People in the News: Jul 6, 2009

Premium

Osmetech has appointed Christopher Gleeson to the post of non-executive chairman, and Jon Faiz Kayyem, who invented the company's eSensor technology while at Clinical Micro Sensors, to be vice chairman. Gleeson previously was president and CEO of Ventana Medical Systems, a position he held until after Ventana was purchased by Roche in 2008. Gleeson also previously was general manager of commercial operations for Chiron Diagnostics and he was senior vice president of Bayer Diagnostics.


Signature Genomic Laboratories last week named Marilyn Slovak and Britt Ravnan as laboratory directors.

Slovak joins Signature from City of Hope National Medical Center where she was director of cytogenetics and professor of pathology. She is also an American Board of Medical Genetics-certified clinical cytogeneticist and a founding fellow of the ABMG College. Slovak holds a PhD in regulatory biology from Cleveland State University and completed her postdoc in cytogenetics and molecular genetics at the University of Arizona.

Ravnan joins Signature from Genzyme Genetics in Santa Fe, NM, where she was cytogenetics laboratory director for 11 years. Before Genzyme, Ravnan held the same post at Kaiser Permanente Northern California Regional Cytogenetics Laboratory in San Jose, Calif. Ravnan, who is also ABMG-certified, holds a PhD in genetics from Stanford University and completed her postdoc in medical genetics at the University of California, San Francisco.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.